Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gene Ther ; 21(2): 148-57, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24257347

ABSTRACT

Reduced intensity conditioning (RIC) is desirable for hematopoietic stem cell (HSC) targeted gene therapy; however, RIC may be insufficient for efficient engraftment and inducing immunological tolerance to transgenes. We previously established long-term gene marking in our rhesus macaque autologous HSC transplantation model following 10 Gy total body irradiation (TBI). In this study, we evaluated RIC transplantation with 4 Gy TBI in two rhesus macaques that received equal parts of CD34(+) cells transduced with green fluorescent protein (GFP)-expressing lentiviral vector and empty vector not expressing transgenes. In both animals, equivalently low gene marking between GFP and empty vectors was observed 6 months post-transplantation, even with efficient transduction of CD34(+) cells in vitro. Autologous lymphocyte infusion with GFP marking resulted in an increase of gene marking in lymphocytes in a control animal with GFP tolerance, but not in the two RIC-transplanted animals. In vitro assays revealed strong cellular and humoral immune responses to GFP protein in the two RIC-transplanted animals, but this was not observed in controls. In summary, 4 Gy TBI is insufficient to permit engraftment of genetically modified HSCs and induce immunological tolerance to transgenes. Our findings should help in the design of conditioning regimens in gene therapy trials.


Subject(s)
Antigens, CD34/metabolism , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Graft Survival/immunology , Graft Survival/radiation effects , Hematopoietic Stem Cell Transplantation/methods , Hematopoietic Stem Cells/immunology , Whole-Body Irradiation/methods , Animals , Cells, Cultured , Combined Modality Therapy , Dose-Response Relationship, Radiation , Hematopoietic Stem Cells/radiation effects , Lentivirus/genetics , Macaca mulatta , Models, Animal , Transduction, Genetic , Transgenes , Transplantation Conditioning
2.
Antimicrob Agents Chemother ; 41(4): 812-7, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9087495

ABSTRACT

The inactivation of herpes simplex virus (HSV) by copper was enhanced by the following reducing agents at the indicated relative level: ascorbic acid >> hydrogen peroxide > cysteine. Treatment of HSV-infected cells with combinations of Cu(II) and ascorbate completely inhibited virus plaque formation to below 0.006% of the infectious virus input, while it maintained 30% viability for the host mammalian cells. The logarithm of the surviving fraction of HSV mediated by 1 mg of Cu(II) per liter and 100 mg of reducing agent per liter followed a linear relationship with the reaction time, in which the kinetic rate constant for each reducing agent was -0.87 min(-1) (r = 0.93) for ascorbate, -0.10 min(-1) (r = 0.97) for hydrogen peroxide, and -0.04 min(-1) (r = 0.97) for cysteine. The protective effects of metal chelators and catalase, the lack of effect of superoxide dismutase, and the partial protection conferred by free-radical scavengers suggest that the mechanism of copper-mediated HSV inactivation is similar to that previously reported for copper-mediated DNA damage. The sensitivity exhibited by HSV to Cu(II) and reducing agents, particularly ascorbate, might be useful in the development of therapeutic antiviral agents.


Subject(s)
Copper/pharmacology , Simplexvirus/drug effects , Animals , Antioxidants/pharmacology , Cell Survival/drug effects , Chelating Agents/pharmacology , Chlorocebus aethiops , Free Radical Scavengers/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Kinetics , Reducing Agents/pharmacology , Vero Cells , Viral Plaque Assay
SELECTION OF CITATIONS
SEARCH DETAIL
...